Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy

Title
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy
Authors
Keywords
-
Journal
PROGRESS IN CARDIOVASCULAR DISEASES
Volume 58, Issue 1, Pages 19-31
Publisher
Elsevier BV
Online
2015-05-03
DOI
10.1016/j.pcad.2015.04.004

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started